GlaxoSmithKline Interest Coverage vs Inventory Turnover Analysis

GSK Stock  USD 42.87  0.12  0.28%   
GlaxoSmithKline PLC financial indicator trend analysis is much more than just examining GlaxoSmithKline PLC ADR latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether GlaxoSmithKline PLC ADR is a good investment. Please check the relationship between GlaxoSmithKline PLC Interest Coverage and its Inventory Turnover accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlaxoSmithKline PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

Interest Coverage vs Inventory Turnover

Interest Coverage vs Inventory Turnover Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of GlaxoSmithKline PLC ADR Interest Coverage account and Inventory Turnover. At this time, the significance of the direction appears to have pay attention.
The correlation between GlaxoSmithKline PLC's Interest Coverage and Inventory Turnover is -0.71. Overlapping area represents the amount of variation of Interest Coverage that can explain the historical movement of Inventory Turnover in the same time period over historical financial statements of GlaxoSmithKline PLC ADR, assuming nothing else is changed. The correlation between historical values of GlaxoSmithKline PLC's Interest Coverage and Inventory Turnover is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Interest Coverage of GlaxoSmithKline PLC ADR are associated (or correlated) with its Inventory Turnover. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Inventory Turnover has no effect on the direction of Interest Coverage i.e., GlaxoSmithKline PLC's Interest Coverage and Inventory Turnover go up and down completely randomly.

Correlation Coefficient

-0.71
Relationship DirectionNegative 
Relationship StrengthWeak

Interest Coverage

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.
Most indicators from GlaxoSmithKline PLC's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into GlaxoSmithKline PLC ADR current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlaxoSmithKline PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
At this time, GlaxoSmithKline PLC's Selling General Administrative is quite stable compared to the past year. Discontinued Operations is expected to rise to about 12.7 B this year, although the value of Tax Provision will most likely fall to about 669.3 M.
 2021 2022 2023 2024 (projected)
Interest Expense784M879M775M502.2M
Depreciation And Amortization2.6B2.4B2.3B1.2B

GlaxoSmithKline PLC fundamental ratios Correlations

0.92-0.320.890.50.890.90.770.610.990.370.590.220.16-0.070.950.950.770.970.320.910.710.70.120.940.12
0.92-0.310.830.410.880.980.710.650.90.340.560.020.08-0.150.910.90.810.910.230.870.870.730.030.820.01
-0.32-0.31-0.330.29-0.11-0.36-0.590.0-0.38-0.260.150.240.740.31-0.36-0.21-0.3-0.360.61-0.06-0.380.220.26-0.420.17
0.890.83-0.330.30.890.830.850.450.870.490.520.160.20.050.830.940.740.940.360.870.720.71-0.070.77-0.07
0.50.410.290.30.270.430.10.190.490.20.420.770.560.390.290.350.040.310.560.480.250.330.880.51-0.1
0.890.88-0.110.890.270.830.730.740.840.330.66-0.020.27-0.120.910.970.880.940.430.930.710.92-0.20.730.15
0.90.98-0.360.830.430.830.70.50.890.370.460.080.09-0.090.870.870.740.890.240.820.90.650.080.82-0.08
0.770.71-0.590.850.10.730.70.450.770.550.40.01-0.14-0.10.740.770.780.820.030.670.590.53-0.230.740.0
0.610.650.00.450.190.740.50.450.560.10.73-0.24-0.01-0.370.680.640.740.610.080.720.370.77-0.180.480.35
0.990.9-0.380.870.490.840.890.770.560.310.50.220.12-0.120.940.920.730.950.280.850.70.630.130.970.11
0.370.34-0.260.490.20.330.370.550.10.310.610.320.010.660.330.380.420.410.060.510.330.320.040.22-0.03
0.590.560.150.520.420.660.460.40.730.50.610.210.250.350.570.630.60.580.30.830.320.750.090.350.24
0.220.020.240.160.77-0.020.080.01-0.240.220.320.210.590.680.030.11-0.190.080.570.2-0.120.010.770.25-0.16
0.160.080.740.20.560.270.09-0.14-0.010.120.010.250.590.490.070.23-0.040.130.980.30.050.440.380.09-0.01
-0.07-0.150.310.050.39-0.12-0.09-0.1-0.37-0.120.660.350.680.49-0.18-0.05-0.22-0.090.420.13-0.090.00.42-0.18-0.14
0.950.91-0.360.830.290.910.870.740.680.940.330.570.030.07-0.180.940.870.970.250.870.710.71-0.120.880.27
0.950.9-0.210.940.350.970.870.770.640.920.380.630.110.23-0.050.940.840.980.40.940.70.82-0.080.820.13
0.770.81-0.30.740.040.880.740.780.740.730.420.6-0.19-0.04-0.220.870.840.850.130.80.590.78-0.40.640.29
0.970.91-0.360.940.310.940.890.820.610.950.410.580.080.13-0.090.970.980.850.310.910.750.74-0.110.880.14
0.320.230.610.360.560.430.240.030.080.280.060.30.570.980.420.250.40.130.310.430.180.540.30.260.02
0.910.87-0.060.870.480.930.820.670.720.850.510.830.20.30.130.870.940.80.910.430.650.880.060.720.14
0.710.87-0.380.720.250.710.90.590.370.70.330.32-0.120.05-0.090.710.70.590.750.180.650.55-0.030.65-0.25
0.70.730.220.710.330.920.650.530.770.630.320.750.010.440.00.710.820.780.740.540.880.55-0.140.490.15
0.120.030.26-0.070.88-0.20.08-0.23-0.180.130.040.090.770.380.42-0.12-0.08-0.4-0.110.30.06-0.03-0.140.2-0.22
0.940.82-0.420.770.510.730.820.740.480.970.220.350.250.09-0.180.880.820.640.880.260.720.650.490.20.14
0.120.010.17-0.07-0.10.15-0.080.00.350.11-0.030.24-0.16-0.01-0.140.270.130.290.140.020.14-0.250.15-0.220.14
Click cells to compare fundamentals

GlaxoSmithKline PLC Account Relationship Matchups

GlaxoSmithKline PLC fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets79.7B80.4B79.1B60.1B59.0B32.8B
Short Long Term Debt Total30.5B27.2B24.2B21.0B18.0B11.0B
Other Current Liab755M765M958M2.3B14.3B15.0B
Total Current Liabilities24.1B22.1B23.7B22.8B21.1B11.2B
Total Stockholder Equity12.0B14.6B15.1B10.6B13.3B14.0B
Property Plant And Equipment Net11.3B11.0B10.7B9.6B10.0B7.2B
Net Debt25.8B20.9B19.9B17.3B15.1B8.3B
Accounts Payable14.9B15.8B17.6B16.3B3.7B6.2B
Cash4.7B6.3B4.3B3.7B2.9B2.7B
Non Current Assets Total60.2B60.2B60.4B39.4B40.4B20.9B
Non Currrent Assets Other1.2B1.1B1.8B5.3B634M1.1B
Cash And Short Term Investments4.8B6.4B4.3B7.9B5.2B4.0B
Common Stock Shares Outstanding2.0B2.0B2.0B2.0B4.1B4.3B
Liabilities And Stockholders Equity79.7B80.4B79.1B60.1B59.0B32.8B
Non Current Liabilities Total37.3B37.5B34.1B27.2B25.1B14.3B
Inventory5.9B6.0B5.8B5.1B5.5B3.0B
Other Stockholder Equity5.2B4.9B4.9B5.1B3.2B2.9B
Total Liab61.3B59.6B57.8B50.1B46.2B25.5B
Property Plant And Equipment Gross10.3B11.0B10.7B9.6B20.2B21.2B
Total Current Assets19.5B20.2B18.7B20.8B18.6B11.9B
Short Term Debt6.9B3.7B3.6B4.0B2.8B2.2B
Common Stock1.3B1.3B1.3B1.3B1.3B1.3B
Retained Earnings5.1B6.8B7.9B4.4B7.2B7.6B
Accumulated Other Comprehensive Income641M1.6B642M(48M)1.6B1.7B
Intangible Assets31.0B29.8B30.1B14.3B14.8B11.4B
Other Liab13.7B14.1B13.5B10.2B11.7B14.2B
Long Term Debt22.6B23.4B20.6B17.0B14.2B17.5B
Good Will10.6B10.6B10.6B7.0B6.8B5.3B
Other Current Assets1.6B617M525M7.7B561M533.0M
Property Plant Equipment11.3B11.0B10.7B9.6B8.7B9.7B
Current Deferred Revenue1.4B1.8B1.6B299M222M233.1M
Other Assets5.1B5.3B6.9B6.9B7.9B5.4B
Net Receivables7.1B7.3B8.0B7.1B7.4B6.5B
Net Tangible Assets(30.1B)(25.8B)(25.6B)(10.8B)(12.4B)(13.0B)
Short Long Term Debt6.7B3.5B3.4B3.8B2.7B4.3B
Long Term Debt Total23.6B23.4B20.6B17.0B19.6B20.5B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether GlaxoSmithKline PLC ADR is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if GlaxoSmithKline Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Glaxosmithkline Plc Adr Stock. Highlighted below are key reports to facilitate an investment decision about Glaxosmithkline Plc Adr Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlaxoSmithKline PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for GlaxoSmithKline Stock analysis

When running GlaxoSmithKline PLC's price analysis, check to measure GlaxoSmithKline PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline PLC is operating at the current time. Most of GlaxoSmithKline PLC's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline PLC's price. Additionally, you may evaluate how the addition of GlaxoSmithKline PLC to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Is GlaxoSmithKline PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.77)
Dividend Share
0.58
Earnings Share
3.03
Revenue Per Share
14.97
Quarterly Revenue Growth
0.092
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.